genedrive (LON:GDR) Shares Down 15.1% – What’s Next?

genedrive plc (LON:GDR) dropped 15.1% during trading on Thursday . The stock traded as low as GBX 1.55 ($0.02) and last traded at GBX 1.55 ($0.02). Approximately 5,960,786 shares were traded during mid-day trading, an increase of 109% from the average daily volume of 2,857,632 shares. The stock had previously closed at GBX 1.83 ($0.02).

genedrive Stock Performance

The company has a debt-to-equity ratio of 0.35, a current ratio of 4.60 and a quick ratio of 5.52. The company has a 50 day moving average of GBX 2.05 and a two-hundred day moving average of GBX 2.17. The company has a market capitalization of £8.80 million, a PE ratio of -0.43 and a beta of -0.04.

genedrive (LON:GDR) last posted its quarterly earnings results on Thursday, March 27th. The company reported GBX (0.40) (($0.01)) earnings per share for the quarter. genedrive had a negative return on equity of 191.22% and a negative net margin of 1,412.18%. As a group, equities research analysts predict that genedrive plc will post 209.9999867 earnings per share for the current year.

genedrive Company Profile

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.